Screener
Haemonetics HAE EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
Based on the most recent quarter.
The source filing: Haemonetics’s 10-Q, filed February 5, 2026. Open the filing →
- Filed
- Feb 5, 2026, 6:05 AM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q4 2025
- Accession
- 0000313143-26-000010
FAQ
- What is Haemonetics's EV / EBITDA?
- Haemonetics (HAE) reported EV / EBITDA of 12.7× in Q4 2025.
- How has Haemonetics's EV / EBITDA changed year-over-year?
- Haemonetics's EV / EBITDA decreased by 22.3% year-over-year, from 16.3× to 12.7×.
- What is the long-term trend for Haemonetics's EV / EBITDA?
- Over 4 years (2021 to 2025), Haemonetics's EV / EBITDA has grown at a -23.4% compound annual growth rate (CAGR), from 36× to 12.4×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about Haemonetics's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude